Photoprotection and 5-MOP photochemoprotection from UVR-induced DNA damage in humans: the role of skin type.
AffiliationPhotobiology Department, United Medical School, Guy's Hospital, London, U.K.
MetadataShow full item record
AbstractSites on previously unexposed buttock skin in 18 subjects (skin types I-V) were treated daily for 2 weeks with suberythemogenic doses of solar-simulated radiation (SSR) alone, SSR plus a UVB sunscreen, and SSR plus the same sunscreen with 5-methoxypsoralen at 30 ppm. The three sites of treatment (designated SSR, SSR/S, and SSR/S/5-MOP), and a control site that received no SSR or topical treatment, were challenged with 2MED SSR 1 week after the treatment had ceased. Biopsy samples, taken within 15 min after the challenge dose, were assessed for unscheduled DNA synthesis (UDS, interpreted as a measure of DNA damage), melanin deposition, and stratum corneum thickening. Within a given skin type, when compared with controls, the significant increase in either pigmentation or stratum corneum thickening was similar for SSR and SSR/S/5-MOP. SSR/S inhibited these endpoints. Compared with controls, UDS was significantly reduced in skin types III-V by SSR and in all skin types by SSR/S/5-MOP. SSR/S elicited no effect apart from minimal reductions in skin types IV and V. Thus, the increases in pigmentation and stratum corneum thickening seen in all skin types with SSR and SSR/S/5-MOP were accompanied by reduced UDS in all skin types with SSR/S/5-MOP but only in skin types III-V with SSR. These findings suggest that, although induced pigmentation and stratum corneum thickening may account in part for the reduction of UDS, qualitative differences in induced pigmentation may exist in skin types I-II between SSR and SSR/S/5-MOP treatments. The findings can also be interpreted to indicate that SSR/S/5-MOP treatment can afford protection against DNA damage from subsequent exposure to solar ultraviolet radiation. Risk-benefit considerations on the use of sunscreens with and without 5-MOP are discussed and the conclusion is drawn that the judicious use of 5-MOP sunscreens, particularly in skin types I-II, affords an alternative option to those seeking a suntan.
CitationPhotoprotection and 5-MOP photochemoprotection from UVR-induced DNA damage in humans: the role of skin type. 1991, 97 (5):942-8 J. Invest. Dermatol.
JournalJournal of Investigative Dermatology
- The time of onset and duration of 5-methoxypsoralen photochemoprotection from UVR-induced DNA damage in human skin.
- Authors: Chadwick CA, Potten CS, Cohen AJ, Young AR
- Issue date: 1994 Oct
- Inhibition of UV radiation-induced DNA damage by a 5-methoxypsoralen tan in human skin.
- Authors: Young AR, Potten CS, Chadwick CA, Murphy GM, Cohen AJ
- Issue date: 1988
- Tanning in human skin types II and III offers modest photoprotection against erythema.
- Authors: Sheehan JM, Potten CS, Young AR
- Issue date: 1998 Oct
- DNA damage in UV-irradiated human skin in vivo: automated direct measurement by image analysis (thymine dimers) compared with indirect measurement (unscheduled DNA synthesis) and protection by 5-methoxypsoralen.
- Authors: Potten CS, Chadwick CA, Cohen AJ, Nikaido O, Matsunaga T, Schipper NW, Young AR
- Issue date: 1993 Mar
- A full-UV spectrum absorbing daily use cream protects human skin against biological changes occurring in photoaging.
- Authors: Seité S, Colige A, Piquemal-Vivenot P, Montastier C, Fourtanier A, Lapière C, Nusgens B
- Issue date: 2000 Aug